Diabetic ketoacidosis as a complication of methanol poisoning; a case report. 2022

Azam Erfanifar, and Mahsa Mahjani, and Sara Salimpour, and Nasim Zamani, and Hossein Hassanian-Moghaddam
Department of Internal Medicine, Loghman-Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

BACKGROUND Diabetic ketoacidosis (DKA) is a complication of diabetes presenting with high anion gap metabolic acidosis. Methanol poisoning, on the other hand, is a toxicology emergency which presents with the same feature. We present a case of methanol poisoning who presented with DKA. METHODS A 28-year-old male was referred to us with blurred vision and loss of consciousness three days after ingestion of 1.5 L of an unknown mixture of bootleg alcoholic beverage. He had history of insulin-dependent diabetes and had neglected his insulin shots on the day prior to hospital admission due to progressive loss of consciousness. Vital signs were normal and venous blood gas analysis showed severe metabolic acidosis and a methanol level of 10.2 mg/dL. After eight hours of hemodialysis, he remained unresponsive. Diabetic ketoacidosis was suspected due to positive urine ketone and blood sugar of 411 mg/dL. Insulin infusion was initiated which was followed by full awakening and extubation. He was discharged completely symptom-free after 4 weeks. CONCLUSIONS Diabetic ketoacidosis and methanol poisoning can happen simultaneously in a diabetic patient. Given the analogous high anion gap metabolic acidosis, physicians should pay particular attention to examination of the diabetic patients. Meticulous evaluation for both conditions is highly recommended.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000138 Acidosis A pathologic condition of acid accumulation or depletion of base in the body. The two main types are RESPIRATORY ACIDOSIS and metabolic acidosis, due to metabolic acid build up. Metabolic Acidosis,Acidoses,Acidoses, Metabolic,Acidosis, Metabolic,Metabolic Acidoses
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000432 Methanol A colorless, flammable liquid used in the manufacture of FORMALDEHYDE and ACETIC ACID, in chemical synthesis, antifreeze, and as a solvent. Ingestion of methanol is toxic and may cause blindness. Alcohol, Methyl,Carbinol,Sodium Methoxide,Wood Alcohol,Alcohol, Wood,Methoxide, Sodium,Methyl Alcohol
D014474 Unconsciousness Loss of the ability to maintain awareness of self and environment combined with markedly reduced responsiveness to environmental stimuli. (From Adams et al., Principles of Neurology, 6th ed, pp344-5) Consciousness, Loss of,Unconscious State,Loss of Consciousness,State, Unconscious,Unconscious States
D016883 Diabetic Ketoacidosis A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and extreme HYPERGLYCEMIA. It is characterized by KETOSIS; DEHYDRATION; and depressed consciousness leading to COMA. Acidosis, Diabetic,DKA Diabetic Ketoacidosis,Diabetic Acidosis,Diabetic Ketosis,Ketoacidosis, Diabetic,Ketosis, Diabetic,Acidoses, Diabetic,DKA Diabetic Ketoacidoses,Diabetic Acidoses,Diabetic Ketoacidoses,Diabetic Ketoacidosis, DKA,Diabetic Ketoses,Ketoacidoses, Diabetic,Ketoacidosis, DKA Diabetic,Ketoses, Diabetic

Related Publications

Azam Erfanifar, and Mahsa Mahjani, and Sara Salimpour, and Nasim Zamani, and Hossein Hassanian-Moghaddam
November 2021, World journal of clinical cases,
Azam Erfanifar, and Mahsa Mahjani, and Sara Salimpour, and Nasim Zamani, and Hossein Hassanian-Moghaddam
January 2022, Frontiers in endocrinology,
Azam Erfanifar, and Mahsa Mahjani, and Sara Salimpour, and Nasim Zamani, and Hossein Hassanian-Moghaddam
April 2014, Revista espanola de enfermedades digestivas,
Azam Erfanifar, and Mahsa Mahjani, and Sara Salimpour, and Nasim Zamani, and Hossein Hassanian-Moghaddam
May 1982, Nederlands tijdschrift voor geneeskunde,
Azam Erfanifar, and Mahsa Mahjani, and Sara Salimpour, and Nasim Zamani, and Hossein Hassanian-Moghaddam
December 1976, Polski tygodnik lekarski (Warsaw, Poland : 1960),
Azam Erfanifar, and Mahsa Mahjani, and Sara Salimpour, and Nasim Zamani, and Hossein Hassanian-Moghaddam
May 1993, Medicina clinica,
Azam Erfanifar, and Mahsa Mahjani, and Sara Salimpour, and Nasim Zamani, and Hossein Hassanian-Moghaddam
June 1983, Journal of toxicology. Clinical toxicology,
Azam Erfanifar, and Mahsa Mahjani, and Sara Salimpour, and Nasim Zamani, and Hossein Hassanian-Moghaddam
January 2011, Indian pediatrics,
Azam Erfanifar, and Mahsa Mahjani, and Sara Salimpour, and Nasim Zamani, and Hossein Hassanian-Moghaddam
January 2005, Przeglad lekarski,
Azam Erfanifar, and Mahsa Mahjani, and Sara Salimpour, and Nasim Zamani, and Hossein Hassanian-Moghaddam
September 1995, Arquivos de neuro-psiquiatria,
Copied contents to your clipboard!